SCHEMBL9638607

SCHEMBL9638607

CN(C)C(=O)C(C#N)C(=O)C1CC1

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9639879 0.78 KDM4E (0.31) ALDH1A1
SCHEMBL9204753 0.74 CHRNB2 (0.44) MAPT
SCHEMBL6535681 0.74 EPHX1 (0.31)
SCHEMBL9638528 0.73
SCHEMBL9198607 0.70 MAPT (0.36) ALDH1A1MAPT
SCHEMBL9638558 0.69 DPP4 (0.33)
SCHEMBL12268287 0.69
SCHEMBL9639841 0.68 CAPN1 (0.34) MAPT
SCHEMBL9639801 0.68 KMT2A (0.37) ALDH1A1MAPT
SCHEMBL9789288 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0326107-B1 ANTIARTHRITIC BETA-CYCLOALKYL-BETA-OXOPROPIONITRILES Bristol-Myers Squibb Company (US) 1992-09-02 EP disclosed
US-4888357-A ANTIINFLAMMATORY AGENTS BRISTOL-MYERS COMPANY (US) 1989-12-19 US disclosed
EP-0326107-A1 Antiarthritic beta-cycloalkyl-beta-oxopropionitriles Bristol-Myers Squibb Company (US) 1989-08-02 EP disclosed